Immunome Inc. - Common Stock (IMNM)

CUSIP: 45257U108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock
Shares outstanding
109,968,942
Total 13F shares
2,376,109
Share change
+467,531
Total reported value
$41,107,000
Price per share
$17.30
Number of holders
25
Value change
+$6,432,363
Number of buys
18
Number of sells
19

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 45257U108?
CUSIP 45257U108 identifies IMNM - Immunome Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMNM - Immunome Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Alpine Global Management, LLC
13F
Company
0.72%
795,709
$26,959,000 31 Mar 2021
13F
Prentice Capital Management, LP
13F
Company
0.3%
331,995
$11,248,000 31 Mar 2021
13F
FMR LLC
13F
Company
0.21%
226,456
$7,672,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
0.14%
154,229
$5,225,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
0.1%
112,851
$3,824,000 31 Mar 2021
13F
Cerity Partners LLC
13F
Company
0.1%
110,327
$3,738,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
49,331
$1,671,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
0.03%
32,550
$1,103,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.02%
27,114
$918,000 31 Mar 2021
13F
Baldwin Investment Management, LLC
13F
Company
0.02%
25,394
$860,000 31 Mar 2021
13F
Magnus Financial Group LLC
13F
Company
0.01%
14,648
$496,000 31 Mar 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
5,857
$198,000 31 Mar 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0%
3,650
$124,000 31 Mar 2021
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
3,229
$110,000 31 Mar 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0%
3,161
$107,000 31 Mar 2021
13F
ETF MANAGERS GROUP, LLC
13F
Company
0%
3,250
$100,000 31 Mar 2021
13F
O'SHAUGHNESSY ASSET MANAGEMENT, LLC
13F
Company
0%
1,599
$54,000 31 Mar 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1,485
$51,000 31 Mar 2021
13F
STRS OHIO
13F
Company
0%
1,400
$47,000 31 Mar 2021
13F
DEUTSCHE BANK AG\
13F
Company
0%
1,340
$45,000 31 Mar 2021
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0%
1,218
$41,000 31 Mar 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
662
$22,000 31 Mar 2021
13F
UBS Group AG
13F
Company
0%
448
$15,000 31 Mar 2021
13F
ROYAL BANK OF CANADA
13F
Company
0%
336
$11,000 31 Mar 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
300
$10,000 31 Mar 2021
13F
Legal & General Group Plc
13F
Company
0%
207
$7,000 31 Mar 2021
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
175
$6,000 31 Mar 2021
13F
CITIGROUP INC
13F
Company
0%
140
$5,000 31 Mar 2021
13F
MORGAN STANLEY
13F
Company
0%
120
$4,000 31 Mar 2021
13F
BANK OF MONTREAL /CAN/
13F
Company
0%
59
$2,000 31 Mar 2021
13F
Michael Widlitz
3/4/5
Director
class O/S missing
3,750
28 May 2021

Institutional Holders of Immunome Inc. - Common Stock (IMNM) as of Q2 2021

As of 30 Jun 2021, Immunome Inc. - Common Stock (IMNM) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,376,109 shares. The largest 10 holders included Alpine Global Management, LLC, Prentice Capital Management, LP, VANGUARD GROUP INC, FMR LLC, Cerity Partners LLC, Ridgewood Investments LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, and ROYAL BANK OF CANADA. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
30
Q2 2021 holders
25
Holder diff
-5
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.